← HHS Federal Register rules

Importation of Prescription Drugs

other · Food and Drug Administration · Rule · Published 2020-10-01 · Effective 2020-11-30 · 85 FR 62094

Document

Document number
2020-21522
Federal Register citation
85 FR 62094
CFR reference
21 CFR 1
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2020-10-01
Effective date
2020-11-30
HHS docket
Docket No. FDA-2019-N-5711

Abstract

The Secretary of Health and Human Services (Secretary) is issuing a final rule to implement a provision of the Federal Food, Drug, and Cosmetic Act (FD&C Act) to allow importation of certain prescription drugs from Canada. Under this final rule, States and Indian Tribes, and in certain future circumstances pharmacists and wholesalers, may submit importation program proposals to the Food and Drug Administration (FDA, the Agency, or we) for review and authorization. An importation program may be cosponsored by a State, Indian Tribe, pharmacist, or wholesaler. The final rule contains all requirements necessary for a sponsor to demonstrate that their importation program will pose no additional risk to the public's health and safety. In addition, the final rule requires that the sponsor explain how they will ensure their program will result in a significant reduction in the cost of covered products to the American consumer.

Source

Authoritative
Federal Register document
Machine
JSON-LD · Markdown